Feed aggregator

Iron Horse Acquisitions Corp. Announces Closing of Initial Public Offering

Lastest from Businesswire - Fri, 12/29/2023 - 17:45
TOLUCA LAKE, Calif.--(BUSINESS WIRE)--Iron Horse Acquisitions Corp. Announces Closing of Initial Public Offering

Fourshore Partners Announces Acquisition of Power Funding

Lastest from Businesswire - Fri, 12/29/2023 - 17:45
MIAMI--(BUSINESS WIRE)--Fourshore Partners (Fourshore) announced today its acquisition of Power Funding (“Power”; “Company”), a premier factoring company focused on the oil & gas and transportation industries. Power Funding provides working capital to the oil & gas and trucking industries through the purchase of invoices generated by small- and medium-sized businesses at a discount to provide immediate working capital to such companies. Power positions itself as being a long-term partne

Browning West Issues Letter to Gildan Activewear Shareholders Announcing Intent to Requisition Special Meeting to Reconstitute Board of Directors

Lastest from Businesswire - Fri, 12/29/2023 - 17:45
LOS ANGELES--(BUSINESS WIRE)--Browning West, LP (together with its affiliates, “Browning West” or “we”) is a significant, long-term shareholder of Gildan Activewear Inc. (NYSE: GIL) (TSX: GIL) (“Gildan” or the “Company”), beneficially owning approximately 5.0% of the Company’s outstanding shares. Today, Browning West issued a letter to shareholders announcing its intent to requisition a Special Meeting of Gildan Shareholders (the “Special Meeting”) to provide shareholders an opportunity to reco

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors and Encourages Investors to Contact the Firm Before February 9, 2024

Lastest from Businesswire - Fri, 12/29/2023 - 17:45
NEW YORK--(BUSINESS WIRE)---- $EGRX #classactionlawsuit--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of those who acquired Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) securities during the period from August 8, 2023 through November 28, 2023, inclusive (the “Class Period”). Investors have until February 9, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit. On No

Pages